GlassScriptPhysician profile
Rebecca E Brown
NPI 1154619344
$592.55
in general payments reported to CMS, 2019-2025
11 companies · $18.02 in 2025
The $18.02 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.57 · 2022: $21.25 · 2023: $367 · 2024: $145 · 2025: $18.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $529.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $142.16 | 2023-2024 | Mounjaro, Zepbound, Jardiance |
| Idorsia Pharmaceuticals US INC | $121.91 | 2023-2024 | Quviviq |
| Bayer Healthcare Pharmaceuticals INC. | $76.74 | 2023 | |
| Abbvie INC. | $57.46 | 2023-2024 | |
| Organon LLC | $55.60 | 2024-2025 | Nexplanon |
| Exact Sciences Corporation | $38.65 | 2023-2024 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $25.21 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $21.25 | 2022 | |
| Becton, Dickinson and Company | $20.30 | 2023 | Bd Onclarity |
| Pharmacosmos Therapeutics INC. | $16.91 | 2023 | Monoferric |
| Stryker Corporation | $16.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.